This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Johnson, J E
Right arrow Articles by Hauschka, S D
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Johnson, J E
Right arrow Articles by Hauschka, S D

 Previous Article  |  Next Article 

Mol Cell Biol. 1989 August; 9(8): 3393-3399

Muscle creatine kinase sequence elements regulating skeletal and cardiac muscle expression in transgenic mice.

J E Johnson, B J Wold and S D Hauschka

Biochemistry Department, University of Washington, Seattle 98195.

ABSTRACT

Muscle creatine kinase (MCK) is expressed at high levels only in skeletal and cardiac muscle tissues. Previous in vitro transfection studies of skeletal muscle myoblasts and fibroblasts had identified two MCK enhancer elements and one proximal promoter element, each of which exhibited expression only in differentiated skeletal muscle. In this study, we have identified several regions of the mouse MCK gene that are responsible for tissue-specific expression in transgenic mice. A fusion gene containing 3,300 nucleotides of MCK 5' sequence exhibited chloramphenicol acetyltransferase activity levels that were more than 10(4)-fold higher in skeletal muscle than in other, nonmuscle tissues such as kidney, liver, and spleen. Expression in cardiac muscle was also greater than in these nonmuscle tissues by 2 to 3 orders of magnitude. Progressive 5' deletions from nucleotide -3300 resulted in reduced expression of the transgene, and one of these resulted in a preferential decrease in expression in cardiac tissue relative to that in skeletal muscle. Of the two enhancer sequences analyzed, only one directed high-level expression in both skeletal and cardiac muscle. The other enhancer activated expression only in skeletal muscle. These data reveal a complex set of cis-acting sequences that have differential effects on MCK expression in skeletal and cardiac muscle.


Mol Cell Biol. 1989 August; 9(8): 3393-3399




This article has been cited by other articles:

  • Tsika, R. W., Schramm, C., Simmer, G., Fitzsimons, D. P., Moss, R. L., Ji, J. (2008). Overexpression of TEAD-1 in Transgenic Mouse Striated Muscles Produces a Slower Skeletal Muscle Contractile Phenotype. J. Biol. Chem. 283: 36154-36167 [Abstract] [Full Text]  
  • Himeda, C. L., Ranish, J. A., Hauschka, S. D. (2008). Quantitative Proteomic Identification of MAZ as a Transcriptional Regulator of Muscle-Specific Genes in Skeletal and Cardiac Myocytes. Mol. Cell. Biol. 28: 6521-6535 [Abstract] [Full Text]  
  • Kim, M.-S., Fielitz, J., McAnally, J., Shelton, J. M., Lemon, D. D., McKinsey, T. A., Richardson, J. A., Bassel-Duby, R., Olson, E. N. (2008). Protein Kinase D1 Stimulates MEF2 Activity in Skeletal Muscle and Enhances Muscle Performance. Mol. Cell. Biol. 28: 3600-3609 [Abstract] [Full Text]  
  • Levin, M. C., Monetti, M., Watt, M. J., Sajan, M. P., Stevens, R. D., Bain, J. R., Newgard, C. B., Farese, R. V. Sr., Farese, R. V. Jr. (2007). Increased lipid accumulation and insulin resistance in transgenic mice expressing DGAT2 in glycolytic (type II) muscle. Am. J. Physiol. Endocrinol. Metab. 293: E1772-E1781 [Abstract] [Full Text]  
  • Miner, J. H., Go, G., Cunningham, J., Patton, B. L., Jarad, G. (2006). Transgenic isolation of skeletal muscle and kidney defects in laminin {beta}2 mutant mice: implications for Pierson syndrome. Development 133: 967-975 [Abstract] [Full Text]  
  • Ho, T. H., Bundman, D., Armstrong, D. L., Cooper, T. A. (2005). Transgenic mice expressing CUG-BP1 reproduce splicing mis-regulation observed in myotonic dystrophy. Hum Mol Genet 14: 1539-1547 [Abstract] [Full Text]  
  • Burkin, D. J., Wallace, G. Q., Milner, D. J., Chaney, E. J., Mulligan, J. A., Kaufman, S. J. (2005). Transgenic Expression of {alpha}7{beta}1 Integrin Maintains Muscle Integrity, Increases Regenerative Capacity, Promotes Hypertrophy, and Reduces Cardiomyopathy in Dystrophic Mice. Am. J. Pathol. 166: 253-263 [Abstract] [Full Text]  
  • Lim, W., Neff, E. S., Furlow, J. D. (2004). The mouse muscle creatine kinase promoter faithfully drives reporter gene expression in transgenic Xenopus laevis. Physiol. Genomics 18: 79-86 [Abstract] [Full Text]  
  • Himeda, C. L., Ranish, J. A., Angello, J. C., Maire, P., Aebersold, R., Hauschka, S. D. (2004). Quantitative Proteomic Identification of Six4 as the Trex-Binding Factor in the Muscle Creatine Kinase Enhancer. Mol. Cell. Biol. 24: 2132-2143 [Abstract] [Full Text]  
  • Nguyen, Q.-G. V., Buskin, J. N., Himeda, C. L., Shield, M. A., Hauschka, S. D. (2003). Differences in the Function of Three Conserved E-boxes of the Muscle Creatine Kinase Gene in Cultured Myocytes and in Transgenic Mouse Skeletal and Cardiac Muscle. J. Biol. Chem. 278: 46494-46505 [Abstract] [Full Text]  
  • Squire, S., Raymackers, J.M., Vandebrouck, C., Potter, A., Tinsley, J., Fisher, R., Gillis, J.M., Davies, K.E. (2002). Prevention of pathology in mdx mice by expression of utrophin: analysis using an inducible transgenic expression system. Hum Mol Genet 11: 3333-3344 [Abstract] [Full Text]  
  • Gomez, C. M., Maselli, R. A., Groshong, J., Zayas, R., Wollmann, R. L., Cens, T., Charnet, P. (2002). Active Calcium Accumulation Underlies Severe Weakness in a Panel of Mice with Slow-Channel Syndrome. J. Neurosci. 22: 6447-6457 [Abstract] [Full Text]  
  • Sugarman, M. C., Yamasaki, T. R., Oddo, S., Echegoyen, J. C., Murphy, M. P., Golde, T. E., Jannatipour, M., Leissring, M. A., LaFerla, F. M. (2002). Inclusion body myositis-like phenotype induced by transgenic overexpression of beta APP in skeletal muscle. Proc. Natl. Acad. Sci. USA 99: 6334-6339 [Abstract] [Full Text]  
  • Bosque, P. J., Ryou, C., Telling, G., Peretz, D., Legname, G., DeArmond, S. J., Prusiner, S. B. (2002). Prions in skeletal muscle. Proc. Natl. Acad. Sci. USA 99: 3812-3817 [Abstract] [Full Text]  
  • Merkel, M., Heeren, J., Dudeck, W., Rinninger, F., Radner, H., Breslow, J. L., Goldberg, I. J., Zechner, R., Greten, H. (2002). Inactive Lipoprotein Lipase (LPL) Alone Increases Selective Cholesterol Ester Uptake in Vivo, Whereas in the Presence of Active LPL It Also Increases Triglyceride Hydrolysis and Whole Particle Lipoprotein Uptake. J. Biol. Chem. 277: 7405-7411 [Abstract] [Full Text]  
  • WHEELER, M.T., ALLIKIAN, M.J., HEYDEMANN, A., MCNALLY, E.M. (2002). The Sarcoglycan Complex in Striated and Vascular Smooth Muscle. Cold Spring Harb Symp Quant Biol 67: 389-398 [Abstract]  
  • Aschenbach, W. G., Suzuki, Y., Breeden, K., Prats, C., Hirshman, M. F., Dufresne, S. D., Sakamoto, K., Vilardo, P. G., Steele, M., Kim, J.-H., Jing, S.-l., Goodyear, L. J., DePaoli-Roach, A. A. (2001). The Muscle-specific Protein Phosphatase PP1G/RGL(GM) Is Essential for Activation of Glycogen Synthase by Exercise. J. Biol. Chem. 276: 39959-39967 [Abstract] [Full Text]  
  • Burkin, D. J., Wallace, G. Q., Nicol, K. J., Kaufman, D. J., Kaufman, S. J. (2001). Enhanced Expression of the {alpha}7{beta}1 Integrin Reduces Muscular Dystrophy and Restores Viability in Dystrophic Mice. JCB 152: 1207-1218 [Abstract] [Full Text]  
  • Naya, F. J., Mercer, B., Shelton, J., Richardson, J. A., Williams, R. S., Olson, E. N. (2000). Stimulation of Slow Skeletal Muscle Fiber Gene Expression by Calcineurin in Vivo. J. Biol. Chem. 275: 4545-4548 [Abstract] [Full Text]  
  • Merkel, M., Kako, Y., Radner, H., Cho, I. S., Ramasamy, R., Brunzell, J. D., Goldberg, I. J., Breslow, J. L. (1998). Catalytically inactive lipoprotein lipase expression in muscle of transgenic mice increases very low density lipoprotein uptake: Direct evidence that lipoprotein lipase bridging occurs in vivo. Proc. Natl. Acad. Sci. USA 95: 13841-13846 [Abstract] [Full Text]  
  • Gomez, C. M., Maselli, R., Gundeck, J. E., Chao, M., Day, J. W., Tamamizu, S., Lasalde, J. A., McNamee, M., Wollmann, R. L. (1997). Slow-Channel Transgenic Mice: A Model of Postsynaptic Organellar Degeneration at the Neuromuscular Junction. J. Neurosci. 17: 4170-4179 [Abstract] [Full Text]  
  • Chang, P.-Y., Jensen, J., Printz, R. L., Granner, D. K., Ivy, J. L., Moller, D. E. (1996). Overexpression of Hexokinase II in Transgenic Mice. EVIDENCE THAT INCREASED PHOSPHORYLATION AUGMENTS MUSCLE GLUCOSE UPTAKE. J. Biol. Chem. 271: 14834-14839 [Abstract] [Full Text]  
  • Fabre-Suver, C., Hauschka, S. D. (1996). A Novel Site in the Muscle Creatine Kinase Enhancer Is Required for Expression in Skeletal but Not Cardiac Muscle. J. Biol. Chem. 271: 4646-4652 [Abstract] [Full Text]  
  • Zhang, J.-N., Wilks, J. E., Billadello, J. J. (1995). Characterization of a Nuclear Protein That Interacts with Regulatory Elements in the Human B Creatine Kinase Gene. J. Biol. Chem. 270: 16134-16139 [Abstract] [Full Text]  
  • Grieshammer, U, McGrew, M., Rosenthal, N (1995). Role of methylation in maintenance of positionally restricted transgene expression in developing muscle. Development 121: 2245-2253 [Abstract]  
  • Li, Z, Marchand, P, Humbert, J, Babinet, C, Paulin, D (1993). Desmin sequence elements regulating skeletal muscle-specific expression in transgenic mice. Development 117: 947-959 [Abstract]  
  • Sanes, J.R., Donoghue, M.J., Wallace, M.C., Merlie, J.P. (1992). Rostrocaudal Differences among Muscles Revealed by a Transgene: Graded Expression at Low Copy Number. Cold Spring Harb Symp Quant Biol 57: 451-460 [Abstract]  
  • Mueller, P., Wold, B (1989). In vivo footprinting of a muscle specific enhancer by ligation mediated PCR. Science 246: 780-786 [Abstract]  
  • Zabolotny, J. M., Kim, Y.-B., Peroni, O. D., Kim, J. K., Pani, M. A., Boss, O., Klaman, L. D., Kamatkar, S., Shulman, G. I., Kahn, B. B., Neel, B. G. (2001). Overexpression of the LAR (leukocyte antigen-related) protein-tyrosine phosphatase in muscle causes insulin resistance. Proc. Natl. Acad. Sci. USA 98: 5187-5192 [Abstract] [Full Text]  
  • Sugarman, M. C., Yamasaki, T. R., Oddo, S., Echegoyen, J. C., Murphy, M. P., Golde, T. E., Jannatipour, M., Leissring, M. A., LaFerla, F. M. (2002). Inclusion body myositis-like phenotype induced by transgenic overexpression of beta APP in skeletal muscle. Proc. Natl. Acad. Sci. USA 99: 6334-6339 [Abstract] [Full Text]